Table 1.
Clinical and demographic variables in total sample and in the two MS subgroups.
| Variables | Total sample (N = 63) | Range | ITG group (N = 32) | MTG group (N = 31) | U | p-Value∗ |
|---|---|---|---|---|---|---|
| Age (years)b | 48.27 ± 10.08 (49) | 23–65 | 50.22 ± 8.69 (51.50) | 46.20 ± 11.31 (58.50) | 402.500 | 0.198 |
| Gender (F/M, n)c | 38/25 | – | 20/12 | 18/13 | – | – |
| Education (years)b | 12.24 ± 4.11 (13) | 5–18 | 13.22 ± 3.44 (13) | 11.17 ± 4.60 (9) | 363.500 | 0.058 |
| Disease duration (months)b | 209.39 ± 117.09 (174) | 24.0–504.0 | 212.57 ± 105.25 225) | 205.99 ± 130.28 (167) | 442.000 | 0.592 |
| EDSSa | 5.48 ± 1.47 (6) | 1.5–7.5 | 5.76 ± 1.17 (6) | 5.16 ± 1.71 (5.75) | 416.500 | 0.268 |
| Relapsing remitting (n) | 9 | – | 4 | 5 | – | – |
| Progressive form (n) | 54 | – | 28 | 26 | – | – |
aEDSS, Expanded Disability Status Scale. bValues are mean ± SD; the numbers in brackets represent the median values; Values are frequencyc (Patient’s group were not significantly different for gender, Pearson x2 test = 0.129; p = 0.459); ∗p-value, intergroup difference = Mann-Whitney U-test.